Epitopes recognized by CBV4 responding T cells: Effect of type 1 diabetes and associated HLA-DR-DQ haplotypes

Virology

Volumn 319, Issue 1, 2004, Pages 27-35

  Marttila, Jane ^a,b   Hyöty, Heikki ^a,c   Näntö Salonen, Kirsti ^a,b   Simell, Olli ^a,b   Ilonen, Jorma ^a,b  

^a Juvenile Diabetes Research Foundation International   (United States)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

Author keywords

Cell mediated immunity; Coxsackievirus B4 (CBV4); Enterovirus; HLA; T cell epitope; Type 1 diabetes (T1D)

Indexed keywords

EPITOPE; HLA DR ANTIGEN; NEUTRALIZING ANTIBODY; PEPTIDE DERIVATIVE;

ADOLESCENT; ANAMNESIS; ARTICLE; ASSOCIATION; CELL LINE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B4; COXSACKIE VIRUS INFECTION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; T LYMPHOCYTE;

COXSACKIEVIRUS; ENTEROVIRUS;

EID: 1242271183     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2003.10.011     Document Type: Article

References (30)

1. Andreoletti L., Hober D., Hober Vandenberghe C., Belaich S., Vantyghem M.C., Lefebvre J., Wattre P. Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus. J. Med. Virol. 52:1997;121-127.
2. Baecher-Allan C., Brown J.A., Freeman G.J., Hafler D.A. CD4+CD25 high regulatory cells in human peripheral blood. J. Immunol. 167:2001;1245-1253.
3. Banatvala J.E., Bryant J., Schernthaner G., Borkenstein M., Schober E., Brown D., De Silva L.M., Menser M.A., Silink M. Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet. 1:1985;1409-1412.
4. Beck M.A., Tracy S.M. Evidence for a group-specific enteroviral antigen(s) recognized by human T cells. J. Clin. Microbiol. 28:1990;1822-1827.
5. Frisk G., Fohlman J., Kobbah M., Ewald U., Tuvemo T., Diderholm H., Friman G. High frequency of Coxsackie-B-virus-specific IgM in children developing type I diabetes during a period of high diabetes morbidity. J. Med. Virol. 17:1985;219-227.
6. Hammond K.J.L., Godfrey D.I. NKT cells: potential targets for autoimmune disease therapy. Tissue Antigens. 59:2002;353-363.
7. Henke A., Huber S., Stelzner A., Whitton J.L. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J. Virol. 69:1995;6720-6728.
8. Hiltunen M., Hyöty H., Knip M., Ilonen J., Reijonen H., Vähäsalo P., Roivainen M., Lönnrot M., Leinikki P., Hovi T., Åkerblom H.K. Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. Childhood Diabetes in Finland (DiMe) Study Group. J. Infect. Dis. 175:1997;554-560.
9. Hogle J.M., Chow M., Filman D.J. Three-dimensional structure of poliovirus at 2.9 A resolution. Science. 229:1985;1358-1365.
10. Hyöty H. Enterovirus infections and type 1 diabetes. Ann. Med. 34:2002;138-147.
11. Hyöty H., Hiltunen M., Knip M., Laakkonen M., Vähäsalo P., Karjalainen J., Koskela P., Roivainen M., Leinikki P., Hovi T.et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes. 44:1995;652-657.
12. Jenkins O., Booth J.D., Minor P.D., Almond J.W. The complete nucleotide sequence of coxsackievirus B4 and its comparison to other members of Picornaviridae. J. Gen. Virol. 68:1987;1835-1848.
13. Jones D.B., Crosby I. Proliferative lymphocyte responses to virus antigens homologous to GAD65 in IDDM. Diabetologia. 39:1996;1318-1324.
14. Juhela S., Hyöty H., Hinkkanen A., Elliott J., Roivainen M., Kulmala P., Rahko J., Knip M., Ilonen J. T cell responses to enterovirus antigens and to beta-cell autoantigens in unaffected children positive for IDDM-associated autoantibodies. J. Autoimmun. 12:1999;269-278.
15. Kukreja A., Cost G., Marker J., Zhang C., Sun Z., Lin Su K., Ten S., Sanz M., Exley M., Wilson B., Porcelli S., Maclaren N. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 109:2002;131-140.
16. Laaksonen M., Pastinen T., Sjöroos M., Kuokkanen S., Ruutiainen J., Sumelahti M.-L., Reijonen H., Salonen R., Wikström J., Panelius M., Partanen J., Tienari P.J., Ilonen J. HLA class II associated risk and protection against multiple sclerosis - a Finnish family study. J. Neuroimmunol. 122:2002;140-145.
17. Marttila J., Juhela S., Vaarala O., Hyöty H., Roivainen M., Hinkkanen A., Vilja P., Simell O., Ilonen J. Responses of coxsackievirus B4-specific T-cell lines to 2C protein - characterization of epitopes with special reference to the GAD65 homology region. Virology. 284:2001;131-141.
18. Marttila J., Hyöty H., Vilja P., Härkönen T., Alho A., Roivainen M., Hyypiä T., Ilonen J. T cell epitopes in coxsackievirus B4 structural proteins concentrate in regions conserved between enteroviruses. Virology. 293:2002;217-224.
19. Mateu M.G. Antibody recognition of picornaviruses and escape from neutralization: a structural view. Virus Res. 38:1995;1-24.
20. Minor P.D., Ferguson M., Evans D.M., Almond J.W., Icenogle J.P. Antigenic structure of polioviruses of serotypes 1, 2 and 3. J. Gen. Virol. 67:1986;1283-1291.
21. Nairn C., Galbraith D.N., Taylor K.W., Clements G.B. Enterovirus variants in the serum of children at the onset of Type 1 diabetes mellitus. Diabet. Med. 16:1999;509-513.
22. Nejetsev S., Sjöroos M., Soukka T., Knip M., Simell O., Lövgren T., Ilonen J. Population-based genetic screening for the estimation of type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci. Diabet. Med. 16:1999;985-992.
23. Pallansch M.A., Roos R.P. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. Knipe D.M., Howley P.M. Fields Virology. vol. 1:2001;723-775 Lippincott Williams & Wilkins, Philadelphia.
24. Pöyry T., Kinnunen L., Hyypiä T., Brown B., Horsnell C., Hovi T., Stanway G. Genetic and phylogenetic clustering of enteroviruses. J. Gen. Virol. 77:1996;1699-1717.
25. Racaniello V.R. Picornaviridae: the viruses and their replication. Knipe D.M., Howley P.M. Fields Virology. vol. 1:2001;685-722 Lippincott Williams & Wilkins, Philadelphia.
26. Rammensee H.G., Friede T., Stevanoviic S. MHC ligands and peptide motifs: first listing. Immunogenetics. 41:1995;178-228.
27. Sjöroos M., Iitiä A., Ilonen J., Reijonen H., Lövgren T. Triple-label hybridization assay for type-1 diabetes-related HLA alleles. BioTechniques. 18:1995;870-877.
28. van der Vliet H.J., von Blomberg B.M., Nishi N., Reijm M., Voskuyl A.E., van Bodegraven A.A., Polman C.H., Rustemeyer T., Lips P., van den Eertwegh A.J., Giaccone G., Scheper R.J., Pinedo H.M. Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin. Immunol. 100:2001;144-148.
29. Varela-Calvino R., Ellis R., Sgarbi G., Dayan C.M., Peakman M. Characterization of the T-cell response to coxsackievirus B4: evidence that effector memory cells predominate in patients with type 1 diabetes. Diabetes. 51:2002;1745-1753.
30. Wing K., Ekmark A., Karlsson H., Rudin A., Suri Payer E. Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood. Immunology. 106:2002;190-199.